vs
Side-by-side financial comparison of First Bancorp, Inc (FNLC) and IRONWOOD PHARMACEUTICALS INC (IRWD). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $25.8M, roughly 1.8× First Bancorp, Inc). First Bancorp, Inc runs the higher net margin — 39.4% vs -4.8%, a 44.1% gap on every dollar of revenue. On growth, First Bancorp, Inc posted the faster year-over-year revenue change (17.5% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $34.6M). Over the past eight quarters, First Bancorp, Inc's revenue compounded faster (18.1% CAGR vs -20.2%).
Patriot Bank, N.A. (PNBK) is the bank holding company for Stamford, Connecticut-based Patriot Bank NA, and is traded on NASDAQ as PNBK.
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
FNLC vs IRWD — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $25.8M | $47.7M |
| Net Profit | $10.2M | $-2.3M |
| Gross Margin | — | — |
| Operating Margin | 48.1% | 14.3% |
| Net Margin | 39.4% | -4.8% |
| Revenue YoY | 17.5% | -47.3% |
| Net Profit YoY | 39.7% | -200.9% |
| EPS (diluted) | $0.91 | $0.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $25.8M | $47.7M | ||
| Q3 25 | $24.5M | $122.1M | ||
| Q2 25 | $22.5M | $85.2M | ||
| Q1 25 | $21.8M | $41.1M | ||
| Q4 24 | $22.0M | $90.5M | ||
| Q3 24 | $20.5M | $91.6M | ||
| Q2 24 | $19.2M | $94.4M | ||
| Q1 24 | $18.5M | $74.9M |
| Q4 25 | $10.2M | $-2.3M | ||
| Q3 25 | $9.1M | $40.1M | ||
| Q2 25 | $8.1M | $23.6M | ||
| Q1 25 | $7.1M | $-37.4M | ||
| Q4 24 | $7.3M | $2.3M | ||
| Q3 24 | $7.6M | $3.6M | ||
| Q2 24 | $6.2M | $-860.0K | ||
| Q1 24 | $6.0M | $-4.2M |
| Q4 25 | 48.1% | 14.3% | ||
| Q3 25 | 45.2% | 61.8% | ||
| Q2 25 | 43.7% | 53.2% | ||
| Q1 25 | 39.3% | -70.7% | ||
| Q4 24 | 39.5% | 34.8% | ||
| Q3 24 | 44.6% | 28.0% | ||
| Q2 24 | 38.8% | 26.5% | ||
| Q1 24 | 39.3% | 14.7% |
| Q4 25 | 39.4% | -4.8% | ||
| Q3 25 | 37.0% | 32.8% | ||
| Q2 25 | 35.8% | 27.7% | ||
| Q1 25 | 32.5% | -90.9% | ||
| Q4 24 | 33.1% | 2.5% | ||
| Q3 24 | 36.9% | 4.0% | ||
| Q2 24 | 32.1% | -0.9% | ||
| Q1 24 | 32.5% | -5.6% |
| Q4 25 | $0.91 | $0.01 | ||
| Q3 25 | $0.81 | $0.23 | ||
| Q2 25 | $0.72 | $0.14 | ||
| Q1 25 | $0.63 | $-0.23 | ||
| Q4 24 | $0.66 | $0.03 | ||
| Q3 24 | $0.68 | $0.02 | ||
| Q2 24 | $0.55 | $-0.01 | ||
| Q1 24 | $0.54 | $-0.03 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $215.5M |
| Total DebtLower is stronger | $95.5M | — |
| Stockholders' EquityBook value | $283.1M | $-261.8M |
| Total Assets | $3.2B | $396.9M |
| Debt / EquityLower = less leverage | 0.34× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | $215.5M | ||
| Q3 25 | — | $140.4M | ||
| Q2 25 | — | $92.9M | ||
| Q1 25 | — | $108.5M | ||
| Q4 24 | — | $88.6M | ||
| Q3 24 | — | $88.2M | ||
| Q2 24 | — | $105.5M | ||
| Q1 24 | — | $121.5M |
| Q4 25 | $95.5M | — | ||
| Q3 25 | $95.5M | $199.5M | ||
| Q2 25 | $95.0M | $199.3M | ||
| Q1 25 | $70.0M | $199.2M | ||
| Q4 24 | $95.0M | $199.0M | ||
| Q3 24 | $95.0M | $198.8M | ||
| Q2 24 | $70.0M | $198.6M | ||
| Q1 24 | $70.0M | $398.3M |
| Q4 25 | $283.1M | $-261.8M | ||
| Q3 25 | $274.6M | $-264.2M | ||
| Q2 25 | $265.5M | $-308.2M | ||
| Q1 25 | $259.7M | $-334.1M | ||
| Q4 24 | $252.5M | $-301.3M | ||
| Q3 24 | $256.8M | $-311.3M | ||
| Q2 24 | $244.7M | $-321.7M | ||
| Q1 24 | $242.6M | $-330.5M |
| Q4 25 | $3.2B | $396.9M | ||
| Q3 25 | $3.2B | $396.1M | ||
| Q2 25 | $3.2B | $342.9M | ||
| Q1 25 | $3.2B | $327.2M | ||
| Q4 24 | $3.2B | $350.9M | ||
| Q3 24 | $3.1B | $389.5M | ||
| Q2 24 | $3.1B | $395.6M | ||
| Q1 24 | $3.0B | $438.8M |
| Q4 25 | 0.34× | — | ||
| Q3 25 | 0.35× | — | ||
| Q2 25 | 0.36× | — | ||
| Q1 25 | 0.27× | — | ||
| Q4 24 | 0.38× | — | ||
| Q3 24 | 0.37× | — | ||
| Q2 24 | 0.29× | — | ||
| Q1 24 | 0.29× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $37.8M | $74.6M |
| Free Cash FlowOCF − Capex | $34.6M | $74.6M |
| FCF MarginFCF / Revenue | 133.9% | 156.3% |
| Capex IntensityCapex / Revenue | 12.5% | 0.0% |
| Cash ConversionOCF / Net Profit | 3.72× | — |
| TTM Free Cash FlowTrailing 4 quarters | $55.3M | $127.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $37.8M | $74.6M | ||
| Q3 25 | $12.9M | $47.6M | ||
| Q2 25 | $7.4M | $-15.1M | ||
| Q1 25 | $2.2M | $20.0M | ||
| Q4 24 | $26.0M | $15.2M | ||
| Q3 24 | $9.8M | $9.9M | ||
| Q2 24 | $6.4M | $33.5M | ||
| Q1 24 | $-1.5M | $45.0M |
| Q4 25 | $34.6M | $74.6M | ||
| Q3 25 | $12.6M | $47.6M | ||
| Q2 25 | $7.2M | $-15.1M | ||
| Q1 25 | $828.0K | $19.9M | ||
| Q4 24 | $24.6M | — | ||
| Q3 24 | $9.6M | $9.9M | ||
| Q2 24 | $6.3M | $33.4M | ||
| Q1 24 | $-1.8M | $44.9M |
| Q4 25 | 133.9% | 156.3% | ||
| Q3 25 | 51.4% | 39.0% | ||
| Q2 25 | 32.1% | -17.7% | ||
| Q1 25 | 3.8% | 48.4% | ||
| Q4 24 | 111.7% | — | ||
| Q3 24 | 47.0% | 10.8% | ||
| Q2 24 | 32.9% | 35.4% | ||
| Q1 24 | -9.8% | 60.0% |
| Q4 25 | 12.5% | 0.0% | ||
| Q3 25 | 1.2% | 0.0% | ||
| Q2 25 | 0.6% | 0.0% | ||
| Q1 25 | 6.2% | 0.1% | ||
| Q4 24 | 6.7% | 0.0% | ||
| Q3 24 | 0.5% | 0.0% | ||
| Q2 24 | 0.3% | 0.1% | ||
| Q1 24 | 1.8% | 0.1% |
| Q4 25 | 3.72× | — | ||
| Q3 25 | 1.42× | 1.19× | ||
| Q2 25 | 0.91× | -0.64× | ||
| Q1 25 | 0.31× | — | ||
| Q4 24 | 3.58× | 6.74× | ||
| Q3 24 | 1.29× | 2.71× | ||
| Q2 24 | 1.03× | — | ||
| Q1 24 | -0.25× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
